AAAAAA
Results:
1-8
|
Results: 8
Authors:
Williams, R
James, OFW
Warnes, TW
Morgan, MY
Citation: R. Williams et al., Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study, EUR J GASTR, 12(2), 2000, pp. 203-208
Authors:
Chick, J
Anton, R
Checinski, K
Croop, R
Drummond, DC
Farmer, R
Labriola, D
Marshall, J
Moncrieff, J
Morgan, MY
Peters, T
Ritson, B
Citation: J. Chick et al., A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse, ALC ALCOHOL, 35(6), 2000, pp. 587-593
Authors:
Chick, J
Howlett, H
Morgan, MY
Ritson, B
Citation: J. Chick et al., United Kingdom multicentre acamprosate study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol, ALC ALCOHOL, 35(2), 2000, pp. 176-187
Authors:
Levine, JA
Harris, MM
Morgan, MY
Citation: Ja. Levine et al., Energy expenditure in chronic alcohol abuse, EUR J CL IN, 30(9), 2000, pp. 779-786
Authors:
Soulsby, CT
Morgan, MY
Citation: Ct. Soulsby et My. Morgan, Dietary management of hepatic encephalopathy in cirrhotic patients: surveyof current practice in United Kingdom, BR MED J, 318(7195), 1999, pp. 1391-1391
Authors:
Madden, AM
Morgan, MY
Citation: Am. Madden et My. Morgan, Resting energy expenditure should be measured in patients with cirrhosis, not predicted, HEPATOLOGY, 30(3), 1999, pp. 655-664
Authors:
Madden, AM
Morgan, MY
Citation: Am. Madden et My. Morgan, Patterns of energy intake in patients with cirrhosis and healthy volunteers, BR J NUTR, 82(1), 1999, pp. 41-48
Authors:
Morgan, MY
Citation: My. Morgan, Cerebral magnetic resonance imaging in patients with chronic liver disease, METAB BRAIN, 13(4), 1998, pp. 273-290
Risultati:
1-8
|